Unknown

Dataset Information

Contractility sensor-guided optimization of cardiac resynchronization therapy: results from the RESPOND-CRT trial.


ABSTRACT:

Aims

Although cardiac resynchronization therapy (CRT) is effective in patients with systolic heart failure (HF) and a wide QRS interval, a substantial proportion of patients remain non-responsive. The SonR contractility sensor embedded in the right atrial lead enables individualized automatic optimization of the atrioventricular (AV) and interventricular (VV) timings. The RESPOND-CRT study investigated the safety and efficacy of the contractility sensor system in HF patients undergoing CRT.

Methods and results

RESPOND-CRT was a prospective, randomized, double-blinded, multicentre, non-inferiority trial. Patients were randomized (2:1, respectively) to receive weekly, automatic CRT optimization with SonR vs. an Echo-guided optimization of AV and VV timings. The primary efficac

SUBMITTER: Brugada J 

PROVIDER: S-EPMC5353752 | biostudies-literature | 2017 Mar

REPOSITORIES: biostudies-literature